CD276 is extensively overexpressed on tumor cells and tumor vasculature [261, 262], and serves as a hazardous marker in GBM as it mediates immunosuppression via inhibiting activity of NK cells, inducing invasion and differentiation of tumor cells [263–265]. Here, CD276 is linked to neoplasm.